Human CNS barrier-forming organoids with cerebrospinal fluid production

被引:277
作者
Pellegrini, Laura [1 ]
Bonfio, Claudia [1 ]
Chadwick, Jessica [1 ]
Begum, Farida [1 ]
Skehel, Mark [1 ]
Lancaster, Madeline A. [1 ]
机构
[1] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England
基金
英国医学研究理事会; 欧洲研究理事会;
关键词
CENTRAL-NERVOUS-SYSTEM; CHOROID-PLEXUS; ALZHEIMERS-DISEASE; PROTEOMIC ANALYSIS; MATRIX METALLOPROTEINASES; CEREBRAL ORGANOIDS; APOLIPOPROTEIN-E; CSF BIOMARKER; TUMOR-MARKERS; SPINAL-FLUID;
D O I
10.1126/science.aaz5626
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cerebrospinal fluid (CSF) is a vital liquid, providing nutrients and signaling molecules and clearing out toxic by-products from the brain. The CSF is produced by the choroid plexus (ChP), a protective epithelial barrier that also prevents free entry of toxic molecules or drugs from the blood. Here, we establish human ChP organoids with a selective barrier and CSF-like fluid secretion in self-contained compartments. We show that this in vitro barrier exhibits the same selectivity to small molecules as the ChP in vivo and that ChP-CSF organoids can predict central nervous system (CNS) permeability of new compounds. The transcriptomic and proteomic signatures of ChP-CSF organoids reveal a high degree of similarity to the ChP in vivo. Finally, the intersection of single-cell transcriptomics and proteomic analysis uncovers key human CSF components produced by previously unidentified specialized epithelial subtypes.
引用
收藏
页码:159 / +
页数:58
相关论文
共 130 条
  • [1] Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
    Aberg, Daniel
    Johansson, Per
    Isgaard, Jorgen
    Wallin, Anders
    Johansson, Jan-Ove
    Andreasson, Ulf
    Blennow, Kaj
    Zetterberg, Henrik
    Aberg, N. David
    Svensson, Johan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (03) : 637 - 646
  • [2] Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
    Agah, Elmira
    Zardoui, Arshia
    Saghazadeh, Amene
    Ahmadi, Mona
    Tafakhori, Abbas
    Rezaei, Nima
    [J]. PLOS ONE, 2018, 13 (01):
  • [3] Biomarkers in Spinal Cord Injury: Prognostic Insights and Future Potentials
    Albayar, Ahmed A.
    Roche, Abigail
    Swiatkowski, Przemyslaw
    Antar, Sarah
    Ouda, Nouran
    Emara, Eman
    Smith, Douglas H.
    Ozturk, Ali K.
    Awad, Basem I.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [4] Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
    Angelov, Lilyana
    Doolittle, Nancy D.
    Kraemer, Dale F.
    Siegal, Tali
    Barnett, Gene H.
    Peereboom, David M.
    Stevens, Glen
    McGregor, John
    Jahnke, Kristoph
    Lacy, Cynthia A.
    Hedrick, Nancy A.
    Shalom, Edna
    Ference, Sandra
    Bell, Susan
    Sorenson, Lisa
    Tyson, Rose Marie
    Haluska, Marianne
    Neuwelt, Edward A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3503 - 3509
  • [5] Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation
    Batista Munoz, Albert
    Hadley, Stephanie
    Iriondo Sanz, Marti
    Agut Quijano, Thais
    Camprubi Camprubi, Marta
    [J]. PLOS ONE, 2019, 14 (05):
  • [6] PLASMA-LEVELS OF LEVODOPA AND ITS MAIN METABOLITES IN PARKINSONIAN-PATIENTS AFTER CONVENTIONAL AND CONTROLLED-RELEASE LEVODOPA-CARBIDOPA ASSOCIATIONS
    BENETELLO, P
    FURLANUT, M
    ZARA, G
    BARALDO, M
    HASSAN, E
    [J]. EUROPEAN NEUROLOGY, 1993, 33 (01) : 69 - 73
  • [7] Statistical issues in first-in-human studies on BIA 10=2474: Neglected comparison of protocol against practice
    Bird, Sheila M.
    Bailey, Rosemary A.
    Grieve, Andrew P.
    Senn, Stephen
    [J]. PHARMACEUTICAL STATISTICS, 2017, 16 (02) : 100 - 106
  • [8] Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
    Bjerke, Maria
    Zetterberg, Henrik
    Edman, Ake
    Blennow, Kaj
    Wallin, Anders
    Andreasson, Ulf
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (03) : 665 - 676
  • [9] Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer's Disease Pathology and Shows Differential Expression in Transgenic Mice
    Bonham, Luke W.
    Geier, Ethan G.
    Steele, Natasha Z. R.
    Holland, Dominic
    Miller, Bruce L.
    Dale, Anders M.
    Desikan, Rahul S.
    Yokoyama, Jennifer S.
    [J]. FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [10] Scientists in the dark after fatal French clinical trial
    Butler, Declan
    Callaway, Ewen
    [J]. NATURE, 2016, 529 (7586) : 263 - 264